DailyDoctor Archive Specialties Get app
All cardiology briefings

The edition · Cardiology

Complete revascularisation in STEMI: a pooled signal favours staging the non-culprit lesions

Four randomised trials suggest doing everything at the index procedure may cost lives at one year. Plus occlusion-focused ECG triage, the cardiovascular safety of oral orforglipron, and what observational data can and cannot say about robotic bypass.

The edition in brief

A meta-analysis of four randomised trials (2,651 patients) with STEMI and multivessel disease found higher one-year all-cause mortality when non-culprit lesions were treated during the index procedure rather than staged (HR 1.50, 95% CI 1.02–2.21), with a prediction interval crossing 1 and few deaths, so the signal is fragile. Immediate treatment reduced protocol-defined MI, driven by procedural MI, but not spontaneous MI. In a DIFOCCULT-3 substudy of 4,398 patients without diagnostic ST elevation, an occlusion-focused (OMI/NOMI) approach sent more patients for invasive management within two hours (45.4% vs 13.6%) and identified acute coronary occlusion early more often (35.1% vs 16.7%) than guideline very-high-risk NSTEMI criteria. ACHIEVE-4 showed oral orforglipron was non-inferior to insulin glargine for four-point MACE in 2,749 people with type 2 diabetes and cardiovascular or kidney disease (HR 0.84, 95% CI 0.59–1.20), with less hypoglycaemia and many more gastrointestinal effects. A meta-analysis of nine observational studies linked robotic-assisted CABG with lower mortality, but selection bias is likely. The pearl covers ECG patterns of occlusion without ST elevation.

In this edition
01
Clinical update

Occlusion-focused ECG triage finds more blocked arteries early than NSTEMI risk criteria

When symptoms suggest infarction but the ECG falls short of ST-elevation criteria, look actively for occlusion patterns and involve the cath lab early.

2 min · JACC. Cardiovascular interventionsRead →
Primary outcome
Invasive management within 2 hours and adjudicated acute coronary occlusion
Effect
Early invasive management 45.4% vs 13.6%; occlusion found within 2 hours 35.1% vs 16.7%
02Research

Oral orforglipron matched insulin glargine for cardiovascular safety

Read ACHIEVE-4 as reassurance on safety only; prefer GLP-1 agonists with proven outcome benefit for patients with established cardiovascular disease.

2 min · Lancet (London, England)Read →
03Research

Robotic bypass looks better in observational data — but the patients were chosen

Consider robotic CABG for well-selected patients at high-volume centres, without promising lower mortality.

1 min · Journal of cardiothoracic surgeryRead →
04Pearl

ECG patterns of occlusion that miss STEMI criteria

When chest pain suggests infarction, check for hyperacute T waves, de Winter pattern, posterior changes and aVL depression before calling the ECG non-diagnostic.

1 minRead →
05Practice changer

STEMI with multivessel disease: staging non-culprit PCI may be the safer timing

In stable STEMI with multivessel disease, favour staging the non-culprit PCI over doing it at the index procedure, and make sure it is booked.

2 min · JACC. Cardiovascular interventionsRead →

Read the rest in the app

You have read your two free briefings this month. The app carries all 27 specialties, every morning, free — and this one is waiting in it.

QR code to install Daily Doctor
Get Daily Doctor — free

Scan to keep reading on your phone. No account needed to start.

Tomorrow morning, before your first patient

One edition a day for cardiology, written by the desk, every claim tied to its paper. Six minutes.

Get the app — free